Gland Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE068V01023
NSEID: GLAND
BSEID: 543245

INR

1,750.00

19.15 (1.11%)

BSENSE

Dec 05

BSE+NSE Vol: 1.1 lacs

{
  "main_header": {
    "sid": 1003443,
    "name": "Gland Pharma",
    "stock_name": "Gland Pharma",
    "full_name": "Gland Pharma Ltd",
    "name_url": "stocks-analysis/gland-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,750.00",
    "chg": 19.15,
    "chgp": "1.11%",
    "dir": 1,
    "prev_price": "1,730.85",
    "mcapval": "28,457.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543245,
    "symbol": "GLAND",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE068V01023",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.1 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gland-pharma-1003443-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Gland Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-gland-pharma-technically-bullish-or-bearish-3747947",
        "imagepath": "",
        "date": "2025-12-05 08:48:15",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 04 Dec 2025, Gland Pharma's technical trend has transitioned from a sideways pattern to a mildly bearish stance. This shift is underscored by a confluence of technical indicators that predominantly signal caution. The weekly and monthly Moving Average Convergence Divergence (MACD) readings both indicate mild bearishness, suggesting that momentum is waning over these timeframes.</p>\n<p>Further reinforcing this view, the Bollinger Bands on weekly and monthly charts are bearish, implying that the stock price is trending towards the lower band, often interpreted as a sign of downward pressure. The Dow Theory, a classical method of trend analysis, also aligns with this mildly bearish outlook on both weekly and monthly scales.</p>\n<p>However, the dail..."
      },
      {
        "title": "Gland Pharma’s Market Assessment Reflects Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3747934",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_mojoScore_3747934.png",
        "date": "2025-12-05 08:16:30",
        "description": "Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by shifts in technical indicators, valuation metrics, financial trends, and overall quality parameters. The pharmaceutical company’s stock performance and underlying fundamentals have prompted a revision in market assessment, reflecting both challenges and areas of stability amid evolving sector dynamics."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-faces-mildly-bearish-momentum-amid-technical-downgrade-3747809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3747809.png",
        "date": "2025-12-05 08:10:57",
        "description": "Gland Pharma’s recent trading activity reveals a shift in technical momentum, with a transition from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical sector player."
      },
      {
        "title": "How has been the historical performance of Gland Pharma?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-gland-pharma-3747134",
        "imagepath": "",
        "date": "2025-12-04 22:53:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profitability Trends</strong></p>\n<p>Gland Pharma’s net sales have shown a robust upward trend from ₹2,633.24 crores in March 2020 to ₹5,616.50 crores in March 2025, effectively more than doubling over this period. The company experienced a notable surge between March 2022 and March 2024, with sales peaking at ₹5,664.72 crores in March 2024 before a slight dip in the latest fiscal year. Despite this minor decline, the overall revenue trajectory remains positive, reflecting strong market demand and operational scale.</p>\n<p>Operating profit margins, excluding other income, have moderated from a high of 37.61% in March 2021 to 22.59% in March 2025. This contraction suggests rising costs or pricing pressures, although the company maintained a healthy operating profit of ₹1,268.92 cr..."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-market-underperformance-3740397",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3740397.png",
        "date": "2025-12-02 08:12:06",
        "description": "Gland Pharma’s recent trading activity reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. This development comes amid a backdrop of mixed signals from moving averages, MACD, RSI, and other technical tools, offering investors a complex picture of the stock’s near-term trajectory."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-mixed-market-signals-3737545",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/GlandPharma_technicaldot_3737545.png",
        "date": "2025-12-01 08:04:50",
        "description": "Gland Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a transition from a sideways trend to a mildly bearish stance. While some metrics suggest caution, others indicate pockets of resilience, underscoring the complexity of the stock’s current market behaviour within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-amid-mixed-market-signals-3734741",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GlandPharma_technicaldot_3734741.png",
        "date": "2025-11-28 08:07:49",
        "description": "Gland Pharma’s stock has experienced a notable shift in price momentum, reflecting a complex interplay of technical indicators that suggest a transition from a mildly bullish trend to a more sideways movement. This development comes amid a backdrop of mixed signals from key technical tools such as MACD, RSI, Bollinger Bands, and moving averages, underscoring a period of consolidation for the pharmaceutical company’s shares."
      },
      {
        "title": "Gland Pharma Shows Mixed Technical Signals Amid Mildly Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gland-pharma-technical-momentum-shifts-to-mildly-bullish-amid-mixed-indicator-signals-3732596",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GlandPharma_technicaldot_3732596.png",
        "date": "2025-11-27 08:08:39",
        "description": "Gland Pharma’s recent price action reflects a nuanced shift in momentum, with technical indicators presenting a blend of mildly bullish and bearish signals. The stock’s movement from a sideways trend to a mildly bullish stance invites closer examination of key metrics such as MACD, RSI, moving averages, and volume-based indicators to understand the evolving market sentiment."
      },
      {
        "title": "Gland Pharma’s Market Assessment Reflects Mixed Signals Amidst Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gland-pharma-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3727925",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/GlandPharma_mojoScore_3727925.png",
        "date": "2025-11-25 08:59:45",
        "description": "Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. Despite a largely flat financial performance in the latest quarter, shifts in market assessment highlight the complexities investors face when analysing this pharmaceutical and biotechnology company."
      }
    ],
    "total": 305,
    "sid": "1003443",
    "stock_news_url": "https://www.marketsmojo.com/news/gland-pharma-1003443"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-Nov-2025",
      "details": "Schedule of Analyst/Investor meets",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "07-Nov-2025",
      "details": "Q2FY26 Earnings Call Transcript",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Nov-2025",
      "details": "Q2FY26 Results News Paper Publication",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Gland Pharma Ltd has declared <strong>1800%</strong> dividend, ex-date: 14 Aug 25",
          "dt": "2025-08-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Gland Pharma technically bullish or bearish?

2025-12-05 08:48:15

Technical Trend Overview

As of 04 Dec 2025, Gland Pharma's technical trend has transitioned from a sideways pattern to a mildly bearish stance. This shift is underscored by a confluence of technical indicators that predominantly signal caution. The weekly and monthly Moving Average Convergence Divergence (MACD) readings both indicate mild bearishness, suggesting that momentum is waning over these timeframes.

Further reinforcing this view, the Bollinger Bands on weekly and monthly charts are bearish, implying that the stock price is trending towards the lower band, often interpreted as a sign of downward pressure. The Dow Theory, a classical method of trend analysis, also aligns with this mildly bearish outlook on both weekly and monthly scales.

However, the dail...

Gland Pharma’s Market Assessment Reflects Mixed Financial and Technical Signals

2025-12-05 08:16:30

Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by shifts in technical indicators, valuation metrics, financial trends, and overall quality parameters. The pharmaceutical company’s stock performance and underlying fundamentals have prompted a revision in market assessment, reflecting both challenges and areas of stability amid evolving sector dynamics.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:10:57

Gland Pharma’s recent trading activity reveals a shift in technical momentum, with a transition from a sideways trend to a mildly bearish stance. This change is underscored by a combination of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, reflecting a nuanced market assessment for the pharmaceutical sector player.

How has been the historical performance of Gland Pharma?

2025-12-04 22:53:17

Revenue and Profitability Trends

Gland Pharma’s net sales have shown a robust upward trend from ₹2,633.24 crores in March 2020 to ₹5,616.50 crores in March 2025, effectively more than doubling over this period. The company experienced a notable surge between March 2022 and March 2024, with sales peaking at ₹5,664.72 crores in March 2024 before a slight dip in the latest fiscal year. Despite this minor decline, the overall revenue trajectory remains positive, reflecting strong market demand and operational scale.

Operating profit margins, excluding other income, have moderated from a high of 37.61% in March 2021 to 22.59% in March 2025. This contraction suggests rising costs or pricing pressures, although the company maintained a healthy operating profit of ₹1,268.92 cr...

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-02 08:12:06

Gland Pharma’s recent trading activity reflects a nuanced shift in technical momentum, with key indicators signalling a transition from a mildly bearish stance to a more sideways trend. This development comes amid a backdrop of mixed signals from moving averages, MACD, RSI, and other technical tools, offering investors a complex picture of the stock’s near-term trajectory.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:04:50

Gland Pharma’s recent technical indicators reveal a nuanced shift in price momentum, reflecting a transition from a sideways trend to a mildly bearish stance. While some metrics suggest caution, others indicate pockets of resilience, underscoring the complexity of the stock’s current market behaviour within the Pharmaceuticals & Biotechnology sector.

Gland Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-11-28 08:07:49

Gland Pharma’s stock has experienced a notable shift in price momentum, reflecting a complex interplay of technical indicators that suggest a transition from a mildly bullish trend to a more sideways movement. This development comes amid a backdrop of mixed signals from key technical tools such as MACD, RSI, Bollinger Bands, and moving averages, underscoring a period of consolidation for the pharmaceutical company’s shares.

Gland Pharma Shows Mixed Technical Signals Amid Mildly Bullish Momentum

2025-11-27 08:08:39

Gland Pharma’s recent price action reflects a nuanced shift in momentum, with technical indicators presenting a blend of mildly bullish and bearish signals. The stock’s movement from a sideways trend to a mildly bullish stance invites closer examination of key metrics such as MACD, RSI, moving averages, and volume-based indicators to understand the evolving market sentiment.

Gland Pharma’s Market Assessment Reflects Mixed Signals Amidst Flat Financials

2025-11-25 08:59:45

Gland Pharma’s recent market evaluation reveals a nuanced picture shaped by a combination of technical indicators, valuation metrics, financial trends, and quality parameters. Despite a largely flat financial performance in the latest quarter, shifts in market assessment highlight the complexities investors face when analysing this pharmaceutical and biotechnology company.